About GPhA

2011 Board of Directors & Executive Committee

Board of Directors

2011 GPhA Board Photo_0

Debra Barrett*
Teva Pharmaceuticals USA

Paul Bisaro*
Watson Pharmaceuticals, Inc.

Doug Boothe*
Actavis, Inc.

Chuck Caprariello
Ranbaxy, Inc.

Don DeGolyer*
Sandoz Inc.

David Klaum*
(Fougera) Nycomed U.S., Inc.

Patrick LePore
Par Pharmaceutical, Inc.

Tony Mauro*
Mylan Pharmaceuticals, Inc.

Tom Murphy
Ben Venue Laboratories, Inc

Joseph Renner
Zydus Pharmaceuticals USA Inc.

Tom Silberg
APP Pharmaceuticals, LLC.

Craig Wheeler*
Momenta Pharmaceuticals Inc.

* denotes member of Executive Committee

Executive Committee

Chairman
Paul Bisaro
President and CEO
Watson Pharmaceuticals, Inc.

Craig Wheeler

Secretary/Treasurer
Craig Wheeler
President and CEO
Momenta Pharmaceuticals

Doug Boothe
President and CEO
Actavis, Inc.

David Klaum

David Klaum
Senior Vice President and General Manager
Fougera (Nycomed U.S., Inc.)

TONY MAURO

Vice Chair
Anthony Mauro
President
Mylan Pharmaceuticals

Debra Barrett
Senior Vice President, Government Affairs
Teva Pharmaceuticals USA

Don DeGolyer
President
Sandoz Inc.